Page last updated: 2024-10-30

mesalamine and Endocarditis, Loeffler

mesalamine has been researched along with Endocarditis, Loeffler in 2 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Usta, Y1
Ozen, H1
Gurakan, F1
Uslu, N1
Saltik-Temizel, IN1
Demir, H1
Yuce, A1
Tanaka, H1
Katoh, D1
Shimizu, M1
Ohno, T1
Tanaka, S1
Kanda, Y1

Other Studies

2 other studies available for mesalamine and Endocarditis, Loeffler

ArticleYear
Hypereosinophilia due to mesalazine treatment.
    Journal of clinical gastroenterology, 2009, Volume: 43, Issue:4

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Child; Humans; Hypereosinophilic Syndrome; Inflammatory Bow

2009
[A case of neonatal severe hypereosinophilia associated with mesalazine administered during pregnancy].
    Arerugi = [Allergy], 2002, Volume: 51, Issue:12

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Female; Humans; Hypereosinophilic Synd

2002